| Annual Financials | 2015 | 2016 | TTM |
Revenue  | 171 | 192 | 0 |
| Expenses | 143 | 156 | 0 |
| EBITDA | 28 | 37 | 0 |
| Operating Profit % | 14 % | 16 % | 0 % |
| Depreciation | 3 | 3 | 0 |
| Interest | 1 | 0 | 0 |
| Profit Before Tax | 24 | 32 | 0 |
| Tax | 9 | 12 | 0 |
| Net Profit | 15 | 21 | 0 |
| EPS in ₹ | 10.31 | 14.08 | 0.00 |
Amrutanjan Health Care
Amrutanjan Health Care
725.30
-12.85
(-1.74%)
Market Cap
2,096.90 Cr
EPS
14.08
PE Ratio
38.21
Dividend Yield
0.64 %
Industry
Healthcare52 Week High
842.90
52 Week Low
544.10
PB Ratio
6.38
Debt to Equity
0.02
Sector
Pharmaceuticals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Company News
View All News
Amrutanjan Targets Double-Digit Growth Through Premium Products and Market ExpansionAug 13, 2025
Amrutanjan is pursuing double-digit growth through several strategic initiatives. The company is focusing on premium wellness and pain management products while expanding its sports recovery product range. The growth strategy includes aggressive distribution reach expansion, increased focus on exports, and enhanced digital marketing efforts to boost brand equity.
Amrutanjan Health Care Reports 80% Jump in Quarterly Profit, Schedules AGM for September
Aug 12, 2025
Aug 12, 2025Amrutanjan Health Care Limited reported profit after tax of ₹831.12 lakhs for the quarter ended June 30, 2025, compared to ₹461.56 lakhs in the same quarter last year. Revenue from operations increased to ₹9,404.57 lakhs from ₹8,373.60 lakhs year-on-year. The company's board approved the quarterly financial results and scheduled the 88th Annual General Meeting for September 23, 2025, via video conference. The board appointed SPNP & Associates as secretarial auditors for five years starting April 2025, subject to shareholder approval. Record date for dividend payment and AGM voting eligibility was set for September 16, 2025. Basic earnings per share stood at ₹2.87 compared to ₹1.60 in the previous year quarter.
Amrutanjan Health Care Reports Q4 Results and Dividend AnnouncementMay 15, 2025
Amrutanjan Health Care has announced its Q4 financial results and a dividend recommendation. The company's Q4 revenue increased to 1.35B rupees from 1.27B rupees year-over-year. EBITDA rose to 177M rupees from 162.4M rupees, with the EBITDA margin improving to 13.07% from 12.78%. Net profit for Q4 increased to 151.8M rupees from 136.6M rupees year-over-year. The company has recommended a final dividend of 2.60 rupees per equity share.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,586.70 | #1 3,80,702.50 | 33.18 | #1 54,729.00 | 9.71 | #1 10,980 | -19.84 | 51.86 | |
5,689.50 | 1,51,038.30 | 65.50 | 9,712.00 | 18.67 | 2,191 | 26.74 | 36.39 | |
1,499.40 | 1,21,107.70 | 22.45 | 28,409.50 | 7.12 | 5,291 | 9.88 | 38.89 | |
3,561.00 | 1,20,520.40 | 59.72 | 11,539.40 | 6.99 | 1,911 | 19.91 | 42.61 | |
1,253.10 | 1,04,580.10 | #1 18.40 | 33,741.20 | 16.73 | 5,725 | 1.26 | 46.51 | |
2,482.90 | 1,02,476.40 | 54.18 | 12,744.20 | #1 20.90 | 2,007 | -18.14 | 44.66 | |
975.00 | 98,107.80 | 21.07 | 23,511.00 | 18.55 | 4,615 | 2.60 | 50.50 | |
1,919.80 | 87,676.40 | 23.72 | 22,909.50 | 13.74 | 3,306 | #1 51.64 | 46.16 | |
5,433.00 | 64,959.70 | 28.53 | 13,458.30 | 3.70 | 2,216 | 21.39 | 61.31 | |
1,090.00 | 63,307.40 | 18.84 | 32,345.60 | 9.43 | 3,484 | -10.24 | 53.78 |
Automatic Screeners on ScanX
Forecast
Actual
Growth Rate
Revenue Growth
12.51 %
Net Income Growth
38.26 %
Cash Flow Change
13.01 %
ROE
20.51 %
ROCE
15.30 %
EBITDA Margin (Avg.)
15.48 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 |
| Total Assets | 124 | 140 |
| Fixed Assets | 24 | 29 |
| Current Assets | 83 | 101 |
| Capital Work in Progress | 4 | 1 |
| Investments | 0 | 0 |
| Other Assets | 96 | 111 |
| Total Liabilities | 124 | 140 |
| Current Liabilities | 26 | 28 |
| Non Current Liabilities | 3 | 4 |
| Total Equity | 95 | 109 |
| Reserve & Surplus | 92 | 106 |
| Share Capital | 3 | 3 |
Cash Flow
| Cash Flow | 2015 | 2016 |
| Net Cash Flow | 2 | 12 |
| Investing Activities | -5 | 4 |
| Operating Activities | 18 | 21 |
| Financing Activities | -12 | -13 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
| Promoter | 50.02 % | 50.02 % | 50.02 % | 50.02 % | 50.02 % | 50.02 % | 50.02 % | 50.02 % | 50.04 % | 50.04 % | 50.59 % | 50.59 % | 50.59 % | 50.59 % | 46.52 % | 46.52 % | 46.52 % | 46.52 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.75 % | 0.00 % | 1.38 % | 1.55 % | 2.34 % | 2.30 % | 2.30 % | 2.41 % |
| DIIs | 7.42 % | 7.16 % | 6.82 % | 6.01 % | 6.01 % | 6.03 % | 6.30 % | 6.39 % | 7.18 % | 7.22 % | 7.10 % | 6.88 % | 7.29 % | 7.32 % | 10.60 % | 11.12 % | 11.41 % | 12.70 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 33.69 % | 34.56 % | 35.12 % | 35.63 % | 35.91 % | 35.64 % | 36.09 % | 35.99 % | 35.38 % | 35.03 % | 35.00 % | 34.61 % | 34.17 % | 33.87 % | 34.09 % | 33.73 % | 33.56 % | 32.28 % |
| Others | 8.87 % | 8.25 % | 8.03 % | 8.33 % | 8.05 % | 8.31 % | 7.59 % | 7.60 % | 7.41 % | 7.71 % | 6.57 % | 7.92 % | 6.57 % | 6.67 % | 6.45 % | 6.33 % | 6.22 % | 6.09 % |
| No of Share Holders | 29,474 | 33,717 | 41,640 | 61,367 | 67,323 | 66,173 | 71,064 | 72,104 | 69,947 | 71,428 | 72,002 | 68,404 | 62,664 | 57,169 | 54,536 | 53,856 | 51,674 | 49,431 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 3.85 | 3.05 | 2.15 | 2.1 | 4.2 | 4.6 | 4.6 | 4.6 | 4.6 |
| Dividend Yield (%) | 0.00 | 1.42 | 0.99 | 0.65 | 0.37 | 0.53 | 0.8 | 0.74 | 0.71 | 0.63 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 19 Feb 2021 |  Dividend | ₹ 0.80 /share | 17 Feb 2021 | 526.95 | 569.90 |
| 16 Sept 2021 | Dividend | ₹ 2.60 /share | 15 Sept 2021 | 797.60 | 733.45 |
| 17 Nov 2021 | Dividend | ₹ 1.00 /share | 16 Nov 2021 | 993.60 | 930.45 |
| 21 Feb 2022 | Dividend | ₹ 1.00 /share | 18 Feb 2022 | 838.85 | 789.85 |
| 16 Sept 2022 | Dividend | ₹ 2.60 /share | 14 Sept 2022 | 846.25 | 751.30 |
| 22 Sept 2022 |  Annual General Meeting | NA | 22 Sept 2022 | 768.40 | 724.20 |
| 15 Nov 2022 | Dividend | ₹ 1.00 /share | 14 Nov 2022 | 731.25 | 736.75 |
| 24 Feb 2023 | Dividend | ₹ 1.00 /share | 24 Feb 2023 | 711.75 | 606.95 |
| 14 Sept 2023 | Dividend | ₹ 2.60 /share | 14 Sept 2023 | 599.05 | 628.90 |
| 21 Sept 2023 | Annual General Meeting | NA | 21 Sept 2023 | 648.75 | 629.65 |
| 23 Nov 2023 | Dividend | ₹ 1.00 /share | 23 Nov 2023 | 607.55 | 602.65 |
| 20 Feb 2024 | Dividend | ₹ 1.00 /share | 20 Feb 2024 | 582.40 | 652.25 |
| 17 Sept 2024 | Dividend | ₹ 2.60 /share | 13 Sept 2024 | 729.50 | 785.60 |
| 23 Sept 2024 | Annual General Meeting | NA | 23 Sept 2024 | 755.35 | 799.85 |
| 12 Nov 2024 |  Quarterly Result Announcement | NA | 12 Nov 2024 | 761.80 | 700.10 |
| 22 Nov 2024 | Dividend | ₹ 1.00 /share | 22 Nov 2024 | 700.10 | 705.50 |
| 12 Feb 2025 | Quarterly Result Announcement | NA | 12 Feb 2025 | 665.85 | 631.90 |
| 18 Feb 2025 | Dividend | ₹ 1.00 /share | 18 Feb 2025 | 631.90 | 602.85 |
| 15 May 2025 | Quarterly Result Announcement | NA | 15 May 2025 | 679.40 | 716.45 |
| 12 Aug 2025 | Quarterly Result Announcement | NA | 12 Aug 2025 | 686.90 | 656.50 |
| 16 Sept 2025 | Dividend | ₹ 2.60 /share | 16 Sept 2025 | 716.45 | 761.70 |
| 23 Sept 2025 | Annual General Meeting | NA | 23 Sept 2025 | 656.50 | 759.40 |
Announcements
Closure of Trading Window1 day ago
1 day agoShareholder Meeting / Postal Ballot-Scrutinizers Report3 days ago
3 days agoShareholder Meeting / Postal Ballot-Outcome of AGM3 days ago
3 days agoAnnouncement under Regulation 30 (LODR)-Change in Management4 days ago
4 days agoShareholder Meeting / Postal Ballot-Outcome of AGM4 days ago
4 days agoMonthly Update: Re-Lodgement Of Transfer Request Of Physical SharesSep 15, 2025
Sep 15, 2025Initmation Regarding Special Window For Relodgement Of SharesSep 15, 2025
Sep 15, 2025Reg. 34 (1) Annual Report.Sep 05, 2025
Sep 05, 2025Corrigendum To Annual Report For The Financial Year 2024-2025Sep 05, 2025
Sep 05, 2025Business Responsibility and Sustainability Reporting (BRSR)Aug 29, 2025
Aug 29, 2025Reg. 34 (1) Annual Report.Aug 29, 2025
Aug 29, 202588Th Annual General Meeting Of The Company To Be Held On 23Rd September 2025.Aug 29, 2025
Aug 29, 2025Initmation Regarding 100 Days Campaign - Saksham NiveshakAug 28, 2025
Aug 28, 2025Initmation Regarding 100 Days Campaign - Saksham NiveshakAug 21, 2025
Aug 21, 2025Announcement under Regulation 30 (LODR)-Investor PresentationAug 13, 2025
Aug 13, 2025Record Date For The Final Dividend Is 16 September 2025.Aug 12, 2025
Aug 12, 2025Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended June 30 2025Aug 12, 2025
Aug 12, 2025Board Meeting Intimation for To Consider And Approve The Unaudited Financial Results For The Quarter Ended 30Th June 2025Aug 06, 2025
Aug 06, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 07, 2025
Jul 07, 2025Closure of Trading WindowJun 23, 2025
Jun 23, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 21, 2025
May 21, 2025Investor Presentation For The Quarter And Year Ended 31St March 2025May 19, 2025
May 19, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMay 15, 2025
May 15, 2025Integrated Filing (Financial)May 15, 2025
May 15, 2025Board Meeting Outcome for Financial Results And Dividend For The Year Ended March 31 2025.May 15, 2025
May 15, 2025Board Meeting Intimation for Audited Financial Results For The Quarter And Year Ended 31St March 2025
Recommendation Of Final Dividend For The Year 2024-25May 08, 2025
May 08, 2025Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 29, 2025
Apr 29, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2025
Apr 07, 2025Closure of Trading WindowMar 26, 2025
Mar 26, 2025Disclosure Under Regulation 30 Of SEBI LODR 2015Mar 03, 2025
Mar 03, 2025Disclosure Under Regulation 30 Of SEBI LODR 2015Mar 03, 2025
Mar 03, 2025Announcement under Regulation 30 (LODR)-Investor PresentationFeb 14, 2025
Feb 14, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 14, 2025
Feb 14, 2025Intimation Of Record Date For The Second Interim Dividend.Feb 12, 2025
Feb 12, 2025Integrated Filing (Financial)Feb 12, 2025
Feb 12, 2025Unaudited Financial Results For The Quarter Ended December 31 2024.Feb 12, 2025
Feb 12, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On February 12 2025.Feb 12, 2025
Feb 12, 2025Board Meeting Intimation for Unaudited Finacial Results For The Quarter Ended 31St December 2024 And 2Nd Interim DividendJan 31, 2025
Jan 31, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 07, 2025
Jan 07, 2025Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 13, 2024
Dec 13, 2024Intimation Of Revised Record Date For The Purpose Of 1St Interim Dividend For FY 2024-25.Nov 14, 2024
Nov 14, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 14, 2024
Nov 14, 2024Announcement under Regulation 30 (LODR)-Investor PresentationNov 13, 2024
Nov 13, 2024Unaudited Financial Results - 30.09.2024Nov 12, 2024
Nov 12, 2024Board Meeting Outcome for Outcome Of Board Meeting Held On November 12, 2024Nov 12, 2024
Nov 12, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 06, 2024
Nov 06, 2024Record Date For The Purpose Of Dividend Is 21St November 2024, If ApprovedNov 04, 2024
Nov 04, 2024Board Meeting Intimation for To Consider And Approve, Inter-Alia, The Un-Audited Financial Results Along With The Limited Review Report For The Quarter Ended 30Th September 2024 And Declaration Of 1St Interim Dividend For The Financial Year 2024-25Nov 04, 2024
Nov 04, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateOct 23, 2024
Oct 23, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateOct 22, 2024
Oct 22, 2024Technical Indicators
RSI(14)
Neutral 44.57
ATR(14)
Volatile 20.15
STOCH(9,6)
Neutral 37.06
STOCH RSI(14)
Oversold 0.00
MACD(12,26)
Bearish -4.94
ADX(14)
Strong Trend 29.71
UO(9)
Bearish 44.36
ROC(12)
Downtrend And Accelerating -3.98
WillR(14)
Oversold -84.41
Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 DSP Small Cap Direct Plan-Growth | 0.61% | 0 | 0.04% | -0.01% | |
 ICICI Prudential FMCG Direct-Growth | 2.38% | 0 | 0.03% | -0.13% | |
 Sundaram Small Cap Fund Direct-Growth | 0.00% | 0 | 0.00% | 0.00% |
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
